1 Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. 2 Address correspondence to: Jae-Won Joh, M.D., Ph.D., Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-dong, Gangnam-gu, Seoul 135-710, Korea.
Transplantation. 2014 Apr 27;97 Suppl 8:S36-43. doi: 10.1097/01.tp.0000446274.13310.b9.
Living donor liver transplantation (LDLT) has become an accepted therapeutic option for patients with end-stage liver disease. However, biliary complications remain the major causes of morbidity and mortality for LDLT recipients. Although there are currently no reports of a clear therapeutic algorithm, many approaches have been developed to treat biliary complications, including surgical, endoscopic, and percutaneous transhepatic techniques. Endoscopic treatment is currently the preferred initial treatment for patients that have previously undergone duct-to-duct biliary reconstruction. This article discusses aspects of endoscopic management of biliary complications that occur in adult LDLT.
活体肝移植(LDLT)已成为终末期肝病患者可接受的治疗选择。然而,胆道并发症仍然是 LDLT 受者发病率和死亡率的主要原因。尽管目前尚无明确的治疗方案报告,但已经开发了许多方法来治疗胆道并发症,包括手术、内镜和经皮经肝技术。对于先前进行过胆管对胆管重建的患者,内镜治疗目前是首选的初始治疗方法。本文讨论了成人 LDLT 中发生的胆道并发症的内镜处理的各个方面。